IPO News & Commentary
Get the latest insights on new stocks
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Parkinson’s disease biotech Aspen Neuroscience files for a $100 million IPO 10/09/26
- Emerging markets fintech OPay files for an estimated $500 million US IPO 10/09/26
- Cavity treatment provider vVardis files for an estimated $200 million US IPO 10/09/26
- EV structural components spin-off Simwon America files for a $50 million IPO 10/09/26
- RNA interference biotech City Therapeutics sets terms for $175 million IPO 10/09/26
- Autoimmune and inflammatory diseases biotech TRex Bio prices IPO at $14, the low end of the range 10/09/26
See more
IPO News By Industry
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- Oil and gas equipment maker VME Companies files for a $30 million IPO 09/18/26
- Hornbeck Offshore Services withdraws $100 million IPO; will trade Wednesday after reverse merger with Helix Energy 09/01/26
- US IPO Weekly Recap: Biotech IPOs keep flowing as data center developer DayOne joins the pipeline 10/09/26
- Canadian push-to-talk device maker Siyata PTT withdraws plans for a direct listing on the Nasdaq 10/07/26
- Global data center developer DayOne Data Centers files for an estimated $3.0 billion US IPO 10/05/26
NYSE IPO News
- Emerging markets fintech OPay files for an estimated $500 million US IPO 10/09/26
- Cavity treatment provider vVardis files for an estimated $200 million US IPO 10/09/26
- SPAC Calm Seas Acquisition lowers units offered by 25% ahead of $200 million IPO 10/08/26
- Spinal implant developer Centinel Spine files for a $100 million IPO 10/07/26
- SPAC Arca Nova Acquisition files for a $100 million IPO, targeting the digital asset and AI sectors 10/02/26
Nasdaq IPO News
- US IPO Week Ahead: Biotech remains a bright spot in a 2 IPO week 10/09/26
- US IPO Weekly Recap: Biotech IPOs keep flowing as data center developer DayOne joins the pipeline 10/09/26
- Immunology and inflammation biotech Bambusa Therapeutics files for a $100 million IPO 10/09/26
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Parkinson’s disease biotech Aspen Neuroscience files for a $100 million IPO 10/09/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
US IPO Week Ahead: Biotech remains a bright spot in a 2 IPO week
While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two more on the calendar for the week ahead. RNA interference biotech City Therapeutics (CTY) plans to raise $175 million at a $1.0 billion...read more
US IPO Weekly Recap: Biotech IPOs keep flowing as data center developer DayOne joins the pipeline
Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Autoimmune biotech TRex Bio (TRXB) priced at the low end to raise $117...read more
Immunology and inflammation biotech Bambusa Therapeutics files for a $100 million IPO
Bambusa Therapeutics, a Phase 2 biotech developing bispecific antibodies for inflammatory diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Bambusa Therapeutics is a clinical-stage biotech developing long-acting...read more